CD34 and myocardial infarction: The longitudinal study of patients with myocardial infarction showed a decreasing trend of the number of circulating CD34+ cells, which at day 7 was statistically lower than at admission, although it was higher than that of controls and became comparable to that of controls within 60 days [84].